Baker Bros. Advisors LP Bicycle Therapeutics PLC Call Options Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCYC
# of Institutions
106Shares Held
40.6MCall Options Held
19.6KPut Options Held
16.9K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$56.9 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$43.1 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$32.6 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$27.4 Million0.43% of portfolio
-
Siren, L.L.C. New York, NY1.84MShares$23 Million1.14% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $371M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...